- US-listed companies
- REPLIGEN CORP
- Cash flow
REPLIGEN CORPRGEN
Market cap
$8.9B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 730,136 | 1 | 1 | 2 | 4 | 5 | 7 | 10 | 13 | 17 | 28 | 27 | 26 | 48 |
| Cash from operations | 2 | 13 | 26 | 18 | 15 | 8 | 17 | 33 | 67 | 63 | 119 | 172 | 114 | 175 |
| Capital expenditures | -575,455 | -1,263,647 | -4,634,776 | -5,602,547 | -3 | -4 | -5 | -11 | -19 | -22 | -67 | -85 | -36 | -26 |
| Cash from investing | -5,010,610 | 3 | -17,906,289 | -19,792,229 | 5 | -49 | -98 | -14 | -205 | -201 | -221 | -233 | -123 | -86 |
| Repurchases of common stock | 330,867 | - | - | - | - | - | - | - | - | - | - | - | 14 | - |
| Cash from financing | -330,842 | 1 | 3 | 2 | 1 | 112 | 130 | 3 | 485 | 306 | 1 | -13 | 249 | -83 |
| Free cash flow | ||||||||||||||
| FCF margin (%) |